androgen-deprivation therapy (ADT)

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

androgen-deprivation therapy (ADT)

Sep 12, 2024, 10:04 | Insight

9-year follow-up from the RADICALS-HD trial

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer Institute, shared…

Sep 12, 2024, 09:57 | Insight

Meta-analysis of 20 RCTs with 14,995 Metastatic Castrate-sensitive Prostate Cancer patients

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer Institute, shared…

Aug 28, 2024, 19:19 | Blog

Tyler Seibert: Patient perspective on Prostate Cancer

Tyler Seibert, Assistant Professor in the Division of Radiation Oncology, shared a post by Tony…

Dec 15, 2023, 06:25 | Drugs

Andrew Armstrong: Pleased to share our ARCHES analysis of efficacy, safety, and QOL of enza/ADT in men w/mHSPC by age

Andrew Armstrong, Professor of Medicine, Surgery, Pharmacology and Cancer Biology at the Duke Cancer Institute,…

All: 4 Posts: 1 - 100

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

'

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram

'

WHO Takes a Creative Leap in Raising Awareness for Colorectal Cancer

'

Highlights from 2025 EAU Annual Meeting on Urology

'

OncoDaily and Big Whig Media Announce Partnership: Global Oncology Media Leader Joins Forces with Premier Washington, D.C. Multimedia Powerhouse

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023